Skip to main content
. 2022 Jan 11;3(1):35–41. doi: 10.1302/2633-1462.31.BJO-2021-0051.R1

Table III.

Multivariate analysis assessing risk of infection with non-cephalosporin alternatives.

Variable OR (95% CI) p-value
PJI risk without cefazolin 2.267 (1.2 to 4.4) 0.015*
PJI risk without cefazolin: adjusted 2.389 (1.2 to 4.6) 0.010 *

Adjusted for male sex, BMI, and rheumatologic history.

*

Statistically significant.

Multivariate logistic regression.

CI, confidence interval; OR, odds ratio; PJI, periproshetic joint infection.